Inmar Intelligence reaches agreement with the DEA
The agreement results from 18 months of collaboration between Inmar and DEA officials to interpret regulations on reverse distribution of controlled substances.
Inmar
Inmar Intelligence expands MMCAP partnership with OneRecall launch
The updated contract deepens access to Inmar’s full suite of healthcare services and introduces OneRecall®, an advanced recall management solution.